Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation


The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.

DPT fielding calls from Ben Venue customers

17-Oct-2013 - US contractor DPT says it has received calls from customers of soon-to-close CMO Ben Venue Labs.

Catalent's Brazilian acquisition supports global softgel strategy

10-Oct-2013 - Catalent has continued its softgel expansion in emerging markets with the acquisition of Relthy Laboratórios in Brazil.

McKesson rumoured to be eyeing up Celesio; New CFO - People Gallery

10-Oct-2013 - McKesson Corporation who is said to be in talks to acquire German logistics company Celesio has appointed a new CFO and Executive Director - Welcome to Outsourcing-Pharma's People on the Move....

Cambridge Major Labs and AAIPharma Merge

08-Oct-2013 - AAIPharma says the merger with Cambridge Major Laboratories (CML) will bring clients the benefits of integrated Chemistry and Manufacturing Controls (CMC) services from two high-growth CMOs.

WCCT eyes niche market with early-stage opthalmic acquisition

26-Sep-2013 - WCCT Global has acquired OC Clinical Trials & Consulting to boost its early-stage ophthalmology services and fill a gap in the market, the firm says.

News in brief

PRA completes merger of RPS

25-Sep-2013 - The merger of PRA and RPS has been completed, creating the fourth largest contract research organisation (CRO).

Molecular Profiles to Formulate Psoriasis Drug in Multi-Firm Project

24-Sep-2013 - Molecular Profiles has been chosen to develop topical and solid dose formulations of a preclinical psoriasis treatment as part of a multicompany conglomerate led by Telormedix.

Columbia Labs add Molecular Profiles CEO to board and plans contracting biz

17-Sep-2013 - Recent entrant into the formulation services sector Columbia Laboratories has added Molecular Profiles execs to its board.

Up to 30% of CMO to Exit Biz in Next 10 Years, Report Says

10-Sep-2013 - The CMO market remains highly fragmented with thirty percent of active players likely to exit the business in the next ten years, according to a Frost & Sullivan report.

Patheon's Q3 Sales and CMO Business Bolstered by Banner Integration

09-Sep-2013 - Patheon has reported increased revenue growth for Q3 2013 following the full completion of Banner and says more industry consolidation is likely.


CrownBio Buys Precos for Cancer tech and European Reach

30-Jul-2013 - US CRO Crown BioSciences has acquired Precos citing the UK contractor’s preclinical oncology services and presence in the European market as the key drivers.

CRA Buys Psychiatric Trial Firm CCD

25-Jul-2013 - Clinical Research Advantage (CRA) has acquired the late phase business of Comprehensive Clinical Development (CCD) adding psychiatric clinical trials to its services.

PRA says Clinstar Takeover Offers Quicker and Cheaper Patient Enrollment

05-Mar-2013 - US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.

Quintiles and TPG tight-lipped on latest IPO rumours

29-Jan-2013 - Quintiles and investor TPG Capital declined to comment on rumours the CRO is sizing up banks and preparing for an IPO.

Medpace boost EU device offering through Meditech takeover

20-Nov-2012 - Medpace has acquired Meditech Strategic Consulting in a bid to expand its European clinical trial services.

CRO round-up: collaboration, expansions and small providers teaming-up to take on the big players

14-Nov-2012 - A new personalised medicine-focused partnership for AstraZeneca, expansion in three continents for World Wide clinical and six small CROs team-up to create one super-team. presents a round-up of the...


PCT Europe 2012: Managing risk, emerging markets and industry criticism

08-Nov-2012 - is in Hamburg,Germany this week to meet the CROs, sponsors and academics gathered at PCT Europe to discuss the future of partnerships in clinical trials.

Is Eli Lilly distancing itself from outsourcing?

05-Nov-2012 - Eli Lilly is bringing more production in-house after investing $140m in the expansion of its US insulin site.

News from AAPS

Xcelience plans EU clinical trial supply expansion after opening new US plant

23-Oct-2012 - Xcelience is shopping for a European distributor after opening a new clinical trial supply facility in the US.

Piramal looking for injectables capacity at the right price

15-Oct-2012 - Piramal Healthcare wants to add sterile injectables to its offering but is unwilling to overpay for facilities owned by 'value focused' private equity groups.

Clinipace doubles in size after purchase of Paragon

25-Sep-2012 - Clinipace has bought Californian CRO Paragon Biomedical in a bid to expand its therapeutic expertise.

News in brief

Carestream sells preclinical imaging biz to Bruker

24-Sep-2012 - Carestream Health has offloaded most of its preclinical molecular imaging systems in a deal with Bruker.

Quintiles grants "prime site" status to Comprehensive

20-Sep-2012 - Quintiles has granted Comprehensive Clinical Development first refusal to work on its sponsored clinical trials.

News in brief

Eckert & Ziegler boosts early phase offering with Vitalea Science takeover

11-Sep-2012 - Isotope technology firm Eckert & Ziegler has acquired bioanalytical CRO Vitalea Science.

Improving Biopharma R&D efficiency a mixed blessing for CROs

06-Sep-2012 - Improving efficiency in biopharma research is a “mixed blessing” for contract research organisations (CROs), according to Wells Fargo.

Key Industry Events


Access all events listing

Our events, Events from partners...